Jiří Drahota

General University Hospital in Prague

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (12)

Anna Glaser

Karolinska Institutet

SWEDEN

View details

Ryan Ramanujam

Karolinska Institutet

SWEDEN

View details

Michaela Tyblova

Charles University and General University Hospital in Prague, First Faculty of Medicine

CZECH REPUBLIC

View details

Elena - Flavia Mouresan

Karolinska Institutet

SWEDEN

View details

Peter Vestergaard Rasmussen

Associate professor

Aarhus University

DENMARK

View details

Melinda Magyari

Associate professor

University of Copenhagen

DENMARK

View details

Klara Novotna

CZECH REPUBLIC

View details

Rodden Middleton

Associate Professor of Disease Registers and Health Data

Swansea University

UNITED KINGDOM

View details

Dominika Stastna

Charles University and General University Hospital in Prague, First Faculty of Medicine

CZECH REPUBLIC

View details

Petra Hanulikova

Charles University

CZECH REPUBLIC

View details

Marta Vachova

Head doctor

Krajská zdravotní as Nemocnice Teplice oz

CZECH REPUBLIC

View details

Ali Manouchehrinia

The University of British Columbia

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jiří Drahota

Research Interests

Contact this professor

Articles (13)

COVID‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark

Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry

Big Multiple Sclerosis Data network: an international registry research network

Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder

Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014] (Multiple Sclerosis and Related Disorders (2022) 65, (S2211034822005235), (10.1016/j.msard.2022.104014))

Predictors of treatment switching in the Big Multiple Sclerosis Data Network

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

Oral cladribine in the treatment of multiple sclerosis – data from the national registry ReMuS® registry

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia

Collaborators (12)

Anna Glaser

Ryan Ramanujam

Michaela Tyblova

Elena - Flavia Mouresan

Peter Vestergaard Rasmussen

Melinda Magyari

Klara Novotna

Rodden Middleton

Dominika Stastna

Petra Hanulikova

Marta Vachova

Ali Manouchehrinia

Make your next move.